4//SEC Filing
Hopkins Robert O 4
Accession 0001593968-20-001225
CIK 0000887247other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:10 PM ET
Size
5.8 KB
Accession
0001593968-20-001225
Insider Transaction Report
Form 4
Hopkins Robert O
Chief Financial Officer
Transactions
- Sale
Common Stock
2020-05-18$0.56/sh−6,532$3,659→ 302,199 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The shares were sold to satisfy the withholding and tax obligations relating to the issuance of shares upon the vesting of RSUs previously granted to the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.5502 to $0.585, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]Includes shares of common stock beneficially owned and shares of common stock issuable upon vesting of restricted stock units previously reported in Table 1 of Form 4.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeother
Related Parties
1- filerCIK 0001461736
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 4:10 PM ET
- Size
- 5.8 KB